510(k) Report

510(k) · Cleared

Recalled · Class II · 2023

Eye-Sync

K202927510(k) TraditionalCleared Oct 2, 2021368-day reviewClass II21 CFR 882.1455Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Syncthink, Inc. · QEA Brain Injury Adjunctive Interpretive Oculomotor Assessment Aid

Cleared on Oct 2, 2021 as substantially equivalent to DEN170091 (Oculogica, Inc., 2018) after a 368-day review. Its family tree reaches back 1 generation to 2018. 2 later devices descend from it. It has been recalled once.

Decided
Oct 2, 2021
Review
368 days
Class
Class II
Product code
QEA
Recalls
1
Predicates
1

Its longest line of descent runs back 1 generation to DEN170091 (2018). 2 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2025: 1 descendant cleared2026: 1 descendant clearedReference device: K152915 · Eye-Sync · Syncthink, Inc. · 2016Reference device: K151504 · ICS Impulse · Gn Otometrics · 2015DEN170091 · EyeBOX · Oculogica, Inc. · 2018201620182020202220242026
Descendants, by generation 1 generation forward: 1 descendant2 generations forward: 1 descendant DEN170091 · EyeBOX · Oculogica, Inc. · 20180
  1. Root · 1 generation backDEN170091 EyeBOXOculogica, Inc. · 2018
  2. This deviceK202927 Eye-SyncSyncthink, Inc. · 2021
  3. Descendant · cites it directly · 1 of its ownK242116 EyeBOX EBX-4.1Oculogica, Inc. · 2025
  4. Descendant · 2 generations on · 0 of its ownK254086 EyeBOX SNAPOculogica, Inc. · 2026

Most influential descendants

Showing 2 of 2 · See all
  • K242116EyeBOX EBX-4.1Oculogica, Inc. · 2025 · cites it directly1descendant
  • K254086EyeBOX SNAPOculogica, Inc. · 2026 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1DEN170091EyeBOXOculogica, Inc.2018—
0 (this device)K202927Eye-SyncSyncthink, Inc.2021—
+1K242116EyeBOX EBX-4.1Oculogica, Inc.2025—
+2K254086EyeBOX SNAPOculogica, Inc.2026—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202510
202610
FIG. 1 — Lineage of K202927, 2018–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QEA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QEA device

  1. #1 K242116 EyeBOX EBX-4.1score 13.0 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*DEN170091EyeBOX
Summary page 4
…Assessment Aid Regulation: 882.1455 Classification Panel: Neurology Device Class: 2 Product Code: QEA Predicate Device: Oculogica EyeBOX (DEN170091) Reference Devices: SyncThink EYE-SYNC (K152915), GN Otometric 1068 A/S Type 1085 ICS Impulse (K151504) Intended Us…
Oculogica, Inc.2018—
†K152915Eye-SyncSyncthink, Inc.2016—
†K151504ICS ImpulseGn Otometrics2015—

Also cleared against DEN170091: 1 other device →

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K242116EyeBOX EBX-4.1Oculogica, Inc.20251

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Sep 19, 2023Class IIZ-2114-2025Device DesignEye syncing issues causing the device to be inoperable. Unable to be repaired due to discontinuation of support for the Pico 2 platform, which was no longer in production or serviceable as of August 31, 2023.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K242116 (Oculogica, Inc., 2025) has gone furthest, with 1 descendant of its own.
  • 1 other device also cites its predicate DEN170091.

How does its category compare?

All QEA devices

QEA Brain Injury Adjunctive Interpretive Oculomotor Assessment Aid: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.

FDA decisions per year · QEA

1in 2025

2018: 12019: 12020: 12021: 22025: 12026 (partial year): 1
2007high 2 (2021) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QEA

Too few QEA 510(k)s in any year since 2007 to give a median.

Recalls per year · QEA

No recall names QEA since 2007.

Adverse event reports per year · QEA

No MAUDE report names QEA since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20181—00
20191—00
20201—00
20212—00
20220—00
20230—00
20240—00
20251—00
20261—0—

What is it indicated for?

The EYE-SYNC® is intended for recording, viewing, and analyzing eye movements in support of identifying visual tracking impairment in human subjects. The EYE-SYNC® is intended to record, measure, and analyze eye movements as an aid in the diagnosis of concussion, also known as mild traumatic brain injury (mTBI), within three days of sport-related head injury in patients 17-24 years of age in conjunction with a standard neurological assessment, for use by…

Read the full statement (115 words)

The EYE-SYNC® is intended for recording, viewing, and analyzing eye movements in support of identifying visual tracking impairment in human subjects.

The EYE-SYNC® is intended to record, measure, and analyze eye movements as an aid in the diagnosis of concussion, also known as mild traumatic brain injury (mTBI), within three days of sport-related head injury in patients 17-24 years of age in conjunction with a standard neurological assessment, for use by medical professionals qualified to interpret the results of a concussion assessment examination.

A negative EYE-SYNC® classification corresponds to eye movements that are consistent with a lack of concussion.

A positive EYE-SYNC® classification corresponds to eye movements that may be present in patients with concussion.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K202927: Eye-Sync.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K202927

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026